Saipem wins €800 million Eni contract package including Baleine Phase 3 subsea work
Saipem has secured two contracts from Eni-related companies and partners with an aggregate value of approximately €800 million. The offshore contract from Eni Côte d’Ivoire and its partners covers subsea infrastructure for Baleine Phase 3 off Ivory Coast and is expected to run for about three years using the construction vessels FDS and Shen Da. Enilive separately awarded Saipem an EPC contract for a new deoxygenation unit at its Venice biorefinery in Porto Marghera. Saipem did not disclose the value attributable to either individual contract.
Confirmed development: Saipem announced two awards with a combined value of approximately €800 million. The principal offshore component covers engineering, fabrication, transportation and installation for Baleine Phase 3 in water depths reaching 1,300 metres. The stated scope includes around 50 km of rigid pipelines, associated subsea structures, flexible risers and jumpers, subsea production systems, a 3 km flexible gas-export flowline and 22 km of subsea umbilical. Saipem expects the campaign to last about three years and plans to deploy FDS and Shen Da. The second award covers EPC of a 70-tonne-per-hour deoxygenation unit at Enilive’s Venice biorefinery.
Analytical interpretation: the Baleine award adds a multi-year deepwater installation commitment to Saipem’s offshore workload and creates demand across fabrication, subsea equipment, logistics and construction-vessel services. Deployment of two named vessels provides a useful forward fleet-utilization signal, although the release gives no mobilization dates or vessel-specific schedule. The aggregate €800 million figure cannot be allocated between the offshore and onshore contracts from the disclosed information. The biorefinery award also indicates continuation of the Eni–Saipem collaboration in low-carbon fuels following the previously announced 2025 biojet EPC contract. Extracted relationships are source-supported suggestions pending analyst review, not database-verified records.